Viveve Medical Inc is a leading medical technology company focused on women's health. The company's core values include innovation, quality, and patient-centricity. Through their innovative solutions, Viveve aims to improve the lives of women by addressing various health conditions. Their corporate philosophy emphasizes a commitment to scientific rigor, evidence-based practices, and delivering safe and effective treatments. Viveve Medical Inc prioritizes providing exceptional patient care and improving quality of life through their advanced medical devices. With a strong focus on research and development, the company continues to develop and market innovative solutions to meet the evolving needs of women worldwide.

Viveve Medical Inc is primarily present in various countries and regions across the globe. The company has a global presence with a focus on North America, Europe, Asia, and the Middle East. Viveve Medical Inc has established its operations and market reach in countries like the United States, Canada, Germany, France, the United Kingdom, China, Japan, Australia, and the United Arab Emirates. With its strategic expansion plans, Viveve Medical Inc continues to strengthen its market presence and deliver innovative medical solutions in these key regions, providing its products and services to healthcare professionals and patients worldwide.

Viveve Medical Inc, a leading medical technology company, has achieved several significant milestones. As of now, the company has successfully developed and commercialized its innovative Viveve System. This non-invasive treatment option offers effective vaginal tissue restoration and rejuvenation, addressing conditions such as vaginal laxity. Viveve Medical has also expanded its global presence by obtaining regulatory approvals and launching its products in various countries, including the United States, Canada, and Europe. Moreover, Viveve Medical Inc has made advancements in clinical research, demonstrating the safety and efficacy of its products in multiple studies. These achievements have strengthened Viveve Medical's position as a trusted provider of innovative women's health solutions.

Viveve Medical Inc is a renowned medical technology company that specializes in women's health solutions. Founded in 2005, the company has emerged as a pioneering force in offering non-invasive treatments for common feminine health concerns. Viveve Medical is known for its patented Viveve System, which utilizes radiofrequency energy to stimulate collagen production and improve tissue restoration. With a commitment to innovation and clinical research, the company aims to enhance the lives of women worldwide. Viveve Medical Inc continues to evolve and expand its portfolio of advanced solutions for a range of medical conditions related to women's health.

The main competitors of Viveve Medical Inc in the market are BTL Industries, InMode Ltd, and Lumenis Ltd. These companies also operate in the medical aesthetics industry and offer products and services similar to Viveve Medical Inc. BTL Industries specializes in non-invasive body shaping and tightening, while InMode Ltd is known for its innovative radiofrequency-based aesthetic solutions. Lumenis Ltd is a global leader in energy-based medical solutions, including those for women's health issues. The competition among these companies drives innovation and enhances options for customers seeking medical treatment in the aesthetic field.

Viveve Medical Inc primarily operates in the healthcare industry.

Viveve Medical Inc is a medical technology company specializing in women's health. Its business model revolves around developing and commercializing innovative solutions to address various medical conditions affecting women. The company's flagship product, Viveve System, utilizes cryogen-cooled monopolar radiofrequency (CMRF) technology to provide non-invasive treatment for vaginal laxity. This cutting-edge technology stimulates collagen production and tightens the vaginal tissue, ultimately enhancing sexual function and improving overall quality of life for women. Viveve Medical Inc aims to improve women's health outcomes by offering clinically proven and safe solutions for conditions that often go untreated or undiagnosed.

De Viveve Medical K/W is -0,00.

De Viveve Medical KUV is 0,00.

De AlleAktien Kwaliteitsscore voor Viveve Medical is 4/10.

De verwachte Viveve Medical omzet is 22,33 mln. USD.

De verwachte Viveve Medical winst is -10,61 mln. USD.

Viveve Medical Inc. is an innovative and advanced company in the field of medical technology, specializing in the development and marketing of devices and products for the treatment of sexual dysfunction, incontinence, and other women-specific health problems. The main product of Viveve Medical Inc. is the Viveve System, a non-invasive method for strengthening and tightening vaginal tissue through collagen stimulation. The Viveve System uses targeted radiofrequency energy to stimulate collagen production and firm the vaginal tissue, resulting in improved sexual function, better bladder control, and reduced risk of vaginal dryness. Additionally, Viveve Medical Inc. offers a range of products to improve female health and well-being, including feminine hygiene products, treatments for menstrual discomfort and post-menopausal symptoms, and contraceptive products. The business activities of Viveve Medical Inc. are conducted in three main segments: Cardiovascular/International Markets, US Business, and OEM (Original Equipment Manufacturer). In the Cardiovascular/International Markets segment, the company's activities are focused on marketing its products and services in international markets, as well as developing product and service offerings for cardiovascular diseases. The US Business segment focuses on marketing the Viveve System in the American market and developing new products for marketing in the US. In this segment, Viveve offers a range of services to ensure product quality, reliability, and safety. The OEM segment deals with the development and provision of solutions for custom product needs and requirements of international partners and customers. The company offers customized products and services to meet the needs of its customers. Overall, Viveve Medical Inc.'s business model is focused on providing innovative and high-quality products and services in the field of female health and well-being. By diversifying its activities in various business areas and focusing on the development and marketing of new products and services, Viveve Medical Inc. is well positioned to further expand its leading position in the medical technology industry.

Viveve Medical keert een dividend van 0 USD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Viveve Medical of het bedrijf keert geen dividend uit.

De ISIN van Viveve Medical is US92852W5013.

Het WKN van Viveve Medical is A2QJQB.

De ticker van Viveve Medical is VIVE.

Binnen de laatste 12 maanden betaalde Viveve Medical een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Viveve Medical naar verwachting een dividend van 0 USD betalen.

De dividendrendement van Viveve Medical is momenteel .

Viveve Medical betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Viveve Medical betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 USD verwacht. Dit komt overeen met een dividendrendement van 0 %.

Viveve Medical wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Viveve Medical van 2-11-2024 ter hoogte van 0 USD te ontvangen, moest je het aandeel voor de ex-datum op 2-11-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 2-11-2024.

In het jaar 2023 heeft Viveve Medical 0 USD aan dividenden uitgekeerd.

De dividenden van Viveve Medical worden in USD uitgekeerd.